Insomnia disorder
暂无分享,去创建一个
[1] Lee M Ritterband,et al. Efficacy of an Internet-based behavioral intervention for adults with insomnia. , 2009, Archives of general psychiatry.
[2] M. Sateia,et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. , 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[3] Ronald C Kessler,et al. The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. , 2012, Archives of general psychiatry.
[4] C. Lines,et al. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial , 2014, The Lancet Neurology.
[5] Adam D Bramoweth,et al. Deployment-Related Insomnia in Military Personnel and Veterans , 2013, Current Psychiatry Reports.
[6] A. Pariente,et al. Benzodiazepine use and risk of Alzheimer’s disease: case-control study , 2014, BMJ : British Medical Journal.
[7] D. Dijk,et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders , 2010, Journal of psychopharmacology.
[8] C. Morin,et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. , 2005, Sleep.
[9] A. Krystal,et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. , 2007, Sleep.
[10] Ronald C Kessler,et al. Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). , 2011, Sleep.
[11] Duanping Liao,et al. Insomnia With Objective Short Sleep Duration and Incident Hypertension: The Penn State Cohort , 2012, Hypertension.
[12] I. Janszky,et al. Insomnia and the Risk of Acute Myocardial Infarction: A Population Study , 2011, Circulation.
[13] Duanping Liao,et al. Insomnia With Objective Short Sleep Duration Is Associated With Type 2 Diabetes , 2009, Diabetes Care.
[14] J. Dartigues,et al. Benzodiazepine use and risk of dementia: prospective population based study , 2012, BMJ : British Medical Journal.
[15] T. Roth,et al. Treatment regimen and hypnotic self-administration , 2001, Psychopharmacology.
[16] C. Morin,et al. The natural history of insomnia: a population-based 3-year longitudinal study. , 2009, Archives of internal medicine.
[17] K. Stechuchak,et al. Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. , 2009, Sleep.
[18] M. Bloch,et al. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders , 2013, PloS one.
[19] B. Kolla,et al. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. , 2011, Alcohol and alcoholism.
[20] C. Morin,et al. Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. , 2005, Behaviour research and therapy.
[21] Karim M Khan,et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. , 2009, Archives of internal medicine.
[22] Ronald C. Kessler,et al. Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the A , 2011, Biological Psychiatry.
[23] Kathryn A. Lee,et al. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. , 2004, Clinical therapeutics.
[24] R. I. Reeves. Comparison of Triazolam, Flurazepam, and Placebo as Hypnotics in Geriatric Patients with Insomnia , 1977, Journal of clinical pharmacology.
[25] E. Camargos,et al. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[26] F. Hu,et al. Association Between Insomnia Symptoms and Mortality: A Prospective Study of US Men , 2014, Circulation.
[27] Hans Ivers,et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. , 2009, JAMA.
[28] C. Morin,et al. Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem , 2017, Sleep.
[29] J. Winkelman,et al. National use of prescription medications for insomnia: NHANES 1999-2010. , 2014, Sleep.
[30] P. Becker,et al. Novel therapeutic usage of low-dose doxepin hydrochloride , 2007, Expert opinion on investigational drugs.
[31] C. Alessi,et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. , 2006, Sleep.
[32] T. Joiner,et al. Sleep problems outperform depression and hopelessness as cross-sectional and longitudinal predictors of suicidal ideation and behavior in young adults in the military. , 2012, Journal of affective disorders.
[33] D. Ford,et al. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? , 1989, JAMA.
[34] Maurice M Ohayon,et al. Epidemiology of insomnia: what we know and what we still need to learn. , 2002, Sleep medicine reviews.
[35] M. Partinen,et al. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. , 2009, Sleep.
[36] S. Quello,et al. Gabapentin treatment for alcohol dependence: a randomized clinical trial. , 2014, JAMA internal medicine.
[37] S. Kyle,et al. Insomnia and health-related quality of life. , 2010, Sleep medicine reviews.
[38] Sati Mazumdar,et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. , 2011, Archives of internal medicine.
[39] C. Campanelli. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2012 .
[40] D. Kansagara,et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. , 2016, Annals of internal medicine.
[41] L. Epstein,et al. Neurobehavioral performance impairment in insomnia: relationships with self-reported sleep and daytime functioning. , 2014, Sleep.
[42] K. Brower,et al. Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients , 2003, Psychiatry and clinical neurosciences.
[43] J. Avorn,et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. , 2001, The American journal of psychiatry.
[44] A. Egberts,et al. The Relationship between Benzodiazepine Use and Traffic Accidents , 2010, CNS drugs.
[45] Ellyn E Matthews,et al. Adherence to cognitive behavioral therapy for insomnia: a systematic review. , 2013, Sleep medicine reviews.
[46] A. Harvey,et al. (Mis)perception of sleep in insomnia: a puzzle and a resolution. , 2012, Psychological bulletin.
[47] C. Lines,et al. Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials , 2016, Biological Psychiatry.
[48] Kai Spiegelhalder,et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. , 2011, Journal of affective disorders.
[49] Randon S. Welton,et al. Benzodiazepines for PTSD: A Systematic Review and Meta-Analysis , 2015, Journal of psychiatric practice.
[50] A. Krystal,et al. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. , 2011, Sleep.
[51] P. Gehrman,et al. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review , 2012, BMC Family Practice.
[52] M. Fava,et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. , 1999, The Journal of clinical psychiatry.
[53] W. Rief,et al. Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials , 2014, CNS Drugs.
[54] C. Dufouil,et al. Long-Term Benzodiazepine Use and Cognitive Decline in the Elderly: The Epidemiology of Vascular Aging Study , 2002, Journal of clinical psychopharmacology.
[55] J. Edinger,et al. Sensitivity and specificity of polysomnographic criteria for defining insomnia. , 2013, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[56] I. Janszky,et al. Insomnia and the risk of incident heart failure: a population study. , 2014, European heart journal.
[57] A Niroshan Siriwardena,et al. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. , 2014, Sleep.
[58] A. Krystal,et al. Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. , 2011, Archives of general psychiatry.
[59] J. Coyne,et al. Physicians’ Perspectives on Prescribing Benzodiazepines for Older Adults: A Qualitative Study , 2007, Journal of General Internal Medicine.
[60] B. Sproule,et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits , 2005, BMJ : British Medical Journal.
[61] I. Janszky,et al. Insomnia symptoms and risk for unintentional fatal injuries--the HUNT Study. , 2014, Sleep.
[62] M. Ohayon,et al. Place of chronic insomnia in the course of depressive and anxiety disorders. , 2003, Journal of psychiatric research.
[63] Duanping Liao,et al. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. , 2013, Sleep medicine reviews.
[64] C. Morin,et al. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. , 2004, The American journal of psychiatry.
[65] A. Krystal,et al. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. , 2008, Sleep.
[66] T. Roth,et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. , 2007, Sleep.
[67] M. Bonnet,et al. Hyperarousal and insomnia: state of the science. , 2010, Sleep medicine reviews.
[68] C. Morin,et al. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[69] B. Sproule,et al. Effects of 2-Week Treatment With Temazepam and Diphenhydramine in Elderly Insomniacs: A Randomized, Placebo-Controlled Trial , 2008, Journal of clinical psychopharmacology.
[70] A. Krystal,et al. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. , 2010, Sleep.